Medtronic received information that approximately two years following the implant of a transcatheter pulmonary bioprosthetic valve, it was noted that the cordis palmaz stent appeared fractured.The patient underwent a surgical procedure approximately two months later.No additional adverse patient effects were reported.(b)(4).This report reflects information received by fda in the form of a notification per 803.22 (b)(2).